nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—pancreatic cancer	0.374	1	CbGaD
Nateglinide—UGT1A9—Irinotecan—pancreatic cancer	0.0556	0.108	CbGbCtD
Nateglinide—ORM1—Erlotinib—pancreatic cancer	0.0454	0.0882	CbGbCtD
Nateglinide—ABCC4—Fluorouracil—pancreatic cancer	0.0447	0.0868	CbGbCtD
Nateglinide—ABCC4—Sunitinib—pancreatic cancer	0.034	0.0659	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0241	0.0468	CbGbCtD
Nateglinide—CYP3A7—Tamoxifen—pancreatic cancer	0.0241	0.0468	CbGbCtD
Nateglinide—ALB—Erlotinib—pancreatic cancer	0.0191	0.0371	CbGbCtD
Nateglinide—CYP3A7—Irinotecan—pancreatic cancer	0.0185	0.0359	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0185	0.0359	CbGbCtD
Nateglinide—CYP3A5—Tamoxifen—pancreatic cancer	0.0181	0.0351	CbGbCtD
Nateglinide—ALB—Irinotecan—pancreatic cancer	0.0173	0.0335	CbGbCtD
Nateglinide—ALB—Fluorouracil—pancreatic cancer	0.0166	0.0322	CbGbCtD
Nateglinide—CYP3A5—Erlotinib—pancreatic cancer	0.0154	0.0298	CbGbCtD
Nateglinide—CYP3A5—Irinotecan—pancreatic cancer	0.0139	0.0269	CbGbCtD
Nateglinide—CYP3A7—Docetaxel—pancreatic cancer	0.0135	0.0263	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0135	0.0263	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0135	0.0262	CbGbCtD
Nateglinide—CYP3A7—Sunitinib—pancreatic cancer	0.0135	0.0262	CbGbCtD
Nateglinide—CYP2C9—Tamoxifen—pancreatic cancer	0.0121	0.0235	CbGbCtD
Nateglinide—CYP2D6—Tamoxifen—pancreatic cancer	0.0111	0.0215	CbGbCtD
Nateglinide—CYP3A5—Docetaxel—pancreatic cancer	0.0102	0.0197	CbGbCtD
Nateglinide—CYP3A5—Sunitinib—pancreatic cancer	0.0101	0.0196	CbGbCtD
Nateglinide—CYP2D6—Erlotinib—pancreatic cancer	0.00942	0.0183	CbGbCtD
Nateglinide—CYP2C9—Fluorouracil—pancreatic cancer	0.00893	0.0173	CbGbCtD
Nateglinide—CYP3A4—Tamoxifen—pancreatic cancer	0.00704	0.0137	CbGbCtD
Nateglinide—CYP3A4—Erlotinib—pancreatic cancer	0.00599	0.0116	CbGbCtD
Nateglinide—CYP3A4—Irinotecan—pancreatic cancer	0.00541	0.0105	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—pancreatic cancer	0.00465	0.00902	CbGbCtD
Nateglinide—Flu symptoms—Gemcitabine—pancreatic cancer	0.00429	0.0676	CcSEcCtD
Nateglinide—ORM1—bile—pancreatic cancer	0.00401	0.263	CbGeAlD
Nateglinide—CYP3A4—Docetaxel—pancreatic cancer	0.00396	0.0077	CbGbCtD
Nateglinide—CYP3A4—Sunitinib—pancreatic cancer	0.00395	0.00766	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—pancreatic cancer	0.00295	0.00574	CbGbCtD
Nateglinide—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.00267	1	CbGdCrCtD
Nateglinide—Gastrointestinal symptom NOS—Fluorouracil—pancreatic cancer	0.00124	0.0196	CcSEcCtD
Nateglinide—Arthropathy—Tamoxifen—pancreatic cancer	0.00119	0.0188	CcSEcCtD
Nateglinide—ORM1—gall bladder—pancreatic cancer	0.00111	0.073	CbGeAlD
Nateglinide—ALB—gall bladder—pancreatic cancer	0.000977	0.064	CbGeAlD
Nateglinide—KCNJ11—islet of Langerhans—pancreatic cancer	0.000971	0.0636	CbGeAlD
Nateglinide—ABCC8—islet of Langerhans—pancreatic cancer	0.000894	0.0586	CbGeAlD
Nateglinide—Injury—Tamoxifen—pancreatic cancer	0.000855	0.0135	CcSEcCtD
Nateglinide—UGT1A9—digestive system—pancreatic cancer	0.000833	0.0546	CbGeAlD
Nateglinide—Thirst—Tamoxifen—pancreatic cancer	0.000826	0.013	CcSEcCtD
Nateglinide—Hepatic enzyme increased—Gemcitabine—pancreatic cancer	0.000787	0.0124	CcSEcCtD
Nateglinide—Osteoarthritis—Tamoxifen—pancreatic cancer	0.000786	0.0124	CcSEcCtD
Nateglinide—Hypoglycaemia—Sunitinib—pancreatic cancer	0.00069	0.0109	CcSEcCtD
Nateglinide—PPARG—islet of Langerhans—pancreatic cancer	0.000683	0.0447	CbGeAlD
Nateglinide—KCNJ11—pancreas—pancreatic cancer	0.000682	0.0447	CbGeAlD
Nateglinide—Influenza—Tamoxifen—pancreatic cancer	0.000679	0.0107	CcSEcCtD
Nateglinide—Bronchitis—Tamoxifen—pancreatic cancer	0.000653	0.0103	CcSEcCtD
Nateglinide—ABCC8—pancreas—pancreatic cancer	0.000629	0.0412	CbGeAlD
Nateglinide—Injury—Irinotecan—pancreatic cancer	0.000603	0.0095	CcSEcCtD
Nateglinide—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.000588	0.00925	CcSEcCtD
Nateglinide—Sweating—Tamoxifen—pancreatic cancer	0.000581	0.00915	CcSEcCtD
Nateglinide—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.000567	0.00893	CcSEcCtD
Nateglinide—Bronchitis—Sunitinib—pancreatic cancer	0.00056	0.00881	CcSEcCtD
Nateglinide—Osteoarthritis—Irinotecan—pancreatic cancer	0.000555	0.00873	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Sunitinib—pancreatic cancer	0.000541	0.00852	CcSEcCtD
Nateglinide—Oedema peripheral—Tamoxifen—pancreatic cancer	0.000536	0.00844	CcSEcCtD
Nateglinide—Osteoarthritis—Fluorouracil—pancreatic cancer	0.000531	0.00837	CcSEcCtD
Nateglinide—Erythema multiforme—Tamoxifen—pancreatic cancer	0.000514	0.0081	CcSEcCtD
Nateglinide—SLC15A1—digestive system—pancreatic cancer	0.000513	0.0336	CbGeAlD
Nateglinide—Erythema multiforme—Erlotinib—pancreatic cancer	0.000509	0.00801	CcSEcCtD
Nateglinide—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.000509	0.00801	CcSEcCtD
Nateglinide—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000491	0.00773	CcSEcCtD
Nateglinide—SLC16A1—digestive system—pancreatic cancer	0.000488	0.032	CbGeAlD
Nateglinide—PPARG—pancreas—pancreatic cancer	0.00048	0.0315	CbGeAlD
Nateglinide—Malnutrition—Erlotinib—pancreatic cancer	0.000468	0.00738	CcSEcCtD
Nateglinide—Sweating increased—Irinotecan—pancreatic cancer	0.000467	0.00735	CcSEcCtD
Nateglinide—Influenza—Gemcitabine—pancreatic cancer	0.000467	0.00735	CcSEcCtD
Nateglinide—Oedema peripheral—Sunitinib—pancreatic cancer	0.000459	0.00723	CcSEcCtD
Nateglinide—Back pain—Tamoxifen—pancreatic cancer	0.000458	0.00721	CcSEcCtD
Nateglinide—Back pain—Erlotinib—pancreatic cancer	0.000453	0.00713	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.000446	0.00702	CcSEcCtD
Nateglinide—Erythema multiforme—Sunitinib—pancreatic cancer	0.00044	0.00694	CcSEcCtD
Nateglinide—ABCC4—pancreas—pancreatic cancer	0.000436	0.0286	CbGeAlD
Nateglinide—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000427	0.00672	CcSEcCtD
Nateglinide—Immune system disorder—Sunitinib—pancreatic cancer	0.000421	0.00663	CcSEcCtD
Nateglinide—Jaundice—Irinotecan—pancreatic cancer	0.000417	0.00656	CcSEcCtD
Nateglinide—Cough—Tamoxifen—pancreatic cancer	0.000413	0.00651	CcSEcCtD
Nateglinide—PPARG—digestive system—pancreatic cancer	0.00041	0.0269	CbGeAlD
Nateglinide—Sweating—Irinotecan—pancreatic cancer	0.00041	0.00645	CcSEcCtD
Nateglinide—Cough—Erlotinib—pancreatic cancer	0.000409	0.00644	CcSEcCtD
Nateglinide—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.000408	0.00643	CcSEcCtD
Nateglinide—CYP3A5—islet of Langerhans—pancreatic cancer	0.000406	0.0266	CbGeAlD
Nateglinide—Malnutrition—Sunitinib—pancreatic cancer	0.000405	0.00639	CcSEcCtD
Nateglinide—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.000401	0.00632	CcSEcCtD
Nateglinide—Sweating—Gemcitabine—pancreatic cancer	0.000399	0.00629	CcSEcCtD
Nateglinide—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000394	0.0062	CcSEcCtD
Nateglinide—Back pain—Sunitinib—pancreatic cancer	0.000392	0.00618	CcSEcCtD
Nateglinide—Arthropathy—Epirubicin—pancreatic cancer	0.000392	0.00617	CcSEcCtD
Nateglinide—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000374	0.00588	CcSEcCtD
Nateglinide—ABCC4—digestive system—pancreatic cancer	0.000372	0.0244	CbGeAlD
Nateglinide—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000368	0.0058	CcSEcCtD
Nateglinide—Arthropathy—Doxorubicin—pancreatic cancer	0.000362	0.00571	CcSEcCtD
Nateglinide—Cough—Sunitinib—pancreatic cancer	0.000354	0.00557	CcSEcCtD
Nateglinide—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000353	0.00556	CcSEcCtD
Nateglinide—Immune system disorder—Irinotecan—pancreatic cancer	0.000347	0.00546	CcSEcCtD
Nateglinide—Dyspepsia—Tamoxifen—pancreatic cancer	0.00034	0.00536	CcSEcCtD
Nateglinide—Immune system disorder—Gemcitabine—pancreatic cancer	0.000338	0.00532	CcSEcCtD
Nateglinide—Dyspepsia—Erlotinib—pancreatic cancer	0.000337	0.0053	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000334	0.00525	CcSEcCtD
Nateglinide—Fatigue—Tamoxifen—pancreatic cancer	0.000333	0.00525	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00033	0.0052	CcSEcCtD
Nateglinide—Fatigue—Erlotinib—pancreatic cancer	0.00033	0.00519	CcSEcCtD
Nateglinide—Back pain—Irinotecan—pancreatic cancer	0.000323	0.00509	CcSEcCtD
Nateglinide—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000316	0.00498	CcSEcCtD
Nateglinide—Back pain—Gemcitabine—pancreatic cancer	0.000315	0.00496	CcSEcCtD
Nateglinide—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000313	0.00492	CcSEcCtD
Nateglinide—Urticaria—Tamoxifen—pancreatic cancer	0.000307	0.00483	CcSEcCtD
Nateglinide—Abdominal pain—Tamoxifen—pancreatic cancer	0.000305	0.00481	CcSEcCtD
Nateglinide—Abdominal pain—Erlotinib—pancreatic cancer	0.000302	0.00476	CcSEcCtD
Nateglinide—Cough—Irinotecan—pancreatic cancer	0.000291	0.00459	CcSEcCtD
Nateglinide—Dyspepsia—Sunitinib—pancreatic cancer	0.000291	0.00459	CcSEcCtD
Nateglinide—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00029	0.00456	CcSEcCtD
Nateglinide—Jaundice—Docetaxel—pancreatic cancer	0.000288	0.00454	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000286	0.0045	CcSEcCtD
Nateglinide—CYP3A5—pancreas—pancreatic cancer	0.000286	0.0187	CbGeAlD
Nateglinide—Fatigue—Sunitinib—pancreatic cancer	0.000285	0.00449	CcSEcCtD
Nateglinide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000285	0.00448	CcSEcCtD
Nateglinide—Cough—Gemcitabine—pancreatic cancer	0.000284	0.00447	CcSEcCtD
Nateglinide—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000279	0.0044	CcSEcCtD
Nateglinide—Asthenia—Tamoxifen—pancreatic cancer	0.000277	0.00437	CcSEcCtD
Nateglinide—Increased appetite—Epirubicin—pancreatic cancer	0.000275	0.00433	CcSEcCtD
Nateglinide—Asthenia—Erlotinib—pancreatic cancer	0.000274	0.00432	CcSEcCtD
Nateglinide—Pruritus—Tamoxifen—pancreatic cancer	0.000273	0.0043	CcSEcCtD
Nateglinide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000271	0.00426	CcSEcCtD
Nateglinide—Pruritus—Erlotinib—pancreatic cancer	0.00027	0.00426	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000265	0.00417	CcSEcCtD
Nateglinide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000264	0.00416	CcSEcCtD
Nateglinide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000264	0.00415	CcSEcCtD
Nateglinide—Abdominal pain—Sunitinib—pancreatic cancer	0.000262	0.00412	CcSEcCtD
Nateglinide—Diarrhoea—Erlotinib—pancreatic cancer	0.000262	0.00412	CcSEcCtD
Nateglinide—Oedema peripheral—Docetaxel—pancreatic cancer	0.000261	0.00411	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—pancreatic cancer	0.000259	0.00407	CcSEcCtD
Nateglinide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000257	0.00404	CcSEcCtD
Nateglinide—Dizziness—Tamoxifen—pancreatic cancer	0.000256	0.00402	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—pancreatic cancer	0.000255	0.00401	CcSEcCtD
Nateglinide—Mitiglinide—PPARG—pancreatic cancer	0.000254	1	CrCbGaD
Nateglinide—Dizziness—Erlotinib—pancreatic cancer	0.000253	0.00398	CcSEcCtD
Nateglinide—Erythema multiforme—Docetaxel—pancreatic cancer	0.000251	0.00395	CcSEcCtD
Nateglinide—Vomiting—Tamoxifen—pancreatic cancer	0.000246	0.00387	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000245	0.00386	CcSEcCtD
Nateglinide—CYP3A5—digestive system—pancreatic cancer	0.000244	0.016	CbGeAlD
Nateglinide—Hypersensitivity—Sunitinib—pancreatic cancer	0.000244	0.00384	CcSEcCtD
Nateglinide—Rash—Tamoxifen—pancreatic cancer	0.000244	0.00384	CcSEcCtD
Nateglinide—Dermatitis—Tamoxifen—pancreatic cancer	0.000243	0.00383	CcSEcCtD
Nateglinide—Vomiting—Erlotinib—pancreatic cancer	0.000243	0.00383	CcSEcCtD
Nateglinide—Rash—Erlotinib—pancreatic cancer	0.000241	0.0038	CcSEcCtD
Nateglinide—Dermatitis—Erlotinib—pancreatic cancer	0.000241	0.00379	CcSEcCtD
Nateglinide—CYP2C9—digestive system—pancreatic cancer	0.00024	0.0157	CbGeAlD
Nateglinide—Dyspepsia—Irinotecan—pancreatic cancer	0.00024	0.00378	CcSEcCtD
Nateglinide—Immune system disorder—Docetaxel—pancreatic cancer	0.00024	0.00377	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000239	0.00377	CcSEcCtD
Nateglinide—Asthenia—Sunitinib—pancreatic cancer	0.000237	0.00374	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000235	0.00371	CcSEcCtD
Nateglinide—Fatigue—Irinotecan—pancreatic cancer	0.000235	0.0037	CcSEcCtD
Nateglinide—Pruritus—Sunitinib—pancreatic cancer	0.000234	0.00369	CcSEcCtD
Nateglinide—Malnutrition—Docetaxel—pancreatic cancer	0.000231	0.00364	CcSEcCtD
Nateglinide—Dyspepsia—Fluorouracil—pancreatic cancer	0.00023	0.00362	CcSEcCtD
Nateglinide—Nausea—Tamoxifen—pancreatic cancer	0.00023	0.00361	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000229	0.00361	CcSEcCtD
Nateglinide—Fatigue—Gemcitabine—pancreatic cancer	0.000229	0.00361	CcSEcCtD
Nateglinide—Nausea—Erlotinib—pancreatic cancer	0.000227	0.00358	CcSEcCtD
Nateglinide—Diarrhoea—Sunitinib—pancreatic cancer	0.000226	0.00357	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000225	0.00355	CcSEcCtD
Nateglinide—Influenza—Epirubicin—pancreatic cancer	0.000224	0.00352	CcSEcCtD
Nateglinide—Back pain—Docetaxel—pancreatic cancer	0.000223	0.00352	CcSEcCtD
Nateglinide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000223	0.00351	CcSEcCtD
Nateglinide—PTGS1—digestive system—pancreatic cancer	0.000219	0.0144	CbGeAlD
Nateglinide—Dizziness—Sunitinib—pancreatic cancer	0.000219	0.00345	CcSEcCtD
Nateglinide—Abdominal pain—Irinotecan—pancreatic cancer	0.000215	0.00339	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—pancreatic cancer	0.000215	0.00338	CcSEcCtD
Nateglinide—Vomiting—Sunitinib—pancreatic cancer	0.00021	0.00331	CcSEcCtD
Nateglinide—Rash—Sunitinib—pancreatic cancer	0.000209	0.00329	CcSEcCtD
Nateglinide—Dermatitis—Sunitinib—pancreatic cancer	0.000208	0.00328	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000208	0.00327	CcSEcCtD
Nateglinide—Urticaria—Fluorouracil—pancreatic cancer	0.000207	0.00327	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—pancreatic cancer	0.000207	0.00326	CcSEcCtD
Nateglinide—Palpitations—Docetaxel—pancreatic cancer	0.000204	0.00321	CcSEcCtD
Nateglinide—Cough—Docetaxel—pancreatic cancer	0.000201	0.00317	CcSEcCtD
Nateglinide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000201	0.00316	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—pancreatic cancer	0.000199	0.00313	CcSEcCtD
Nateglinide—Nausea—Sunitinib—pancreatic cancer	0.000197	0.0031	CcSEcCtD
Nateglinide—Asthenia—Irinotecan—pancreatic cancer	0.000196	0.00308	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000195	0.00308	CcSEcCtD
Nateglinide—Jaundice—Epirubicin—pancreatic cancer	0.000194	0.00306	CcSEcCtD
Nateglinide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000192	0.00303	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000192	0.00303	CcSEcCtD
Nateglinide—Sweating—Epirubicin—pancreatic cancer	0.000191	0.00301	CcSEcCtD
Nateglinide—Asthenia—Gemcitabine—pancreatic cancer	0.000191	0.003	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000188	0.00297	CcSEcCtD
Nateglinide—Pruritus—Gemcitabine—pancreatic cancer	0.000188	0.00296	CcSEcCtD
Nateglinide—Diarrhoea—Irinotecan—pancreatic cancer	0.000187	0.00294	CcSEcCtD
Nateglinide—Pruritus—Fluorouracil—pancreatic cancer	0.000185	0.00291	CcSEcCtD
Nateglinide—CYP3A4—digestive system—pancreatic cancer	0.000183	0.012	CbGeAlD
Nateglinide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000182	0.00286	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000181	0.00285	CcSEcCtD
Nateglinide—Dizziness—Irinotecan—pancreatic cancer	0.00018	0.00284	CcSEcCtD
Nateglinide—CYP2D6—digestive system—pancreatic cancer	0.00018	0.0118	CbGeAlD
Nateglinide—Jaundice—Doxorubicin—pancreatic cancer	0.00018	0.00283	CcSEcCtD
Nateglinide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000179	0.00281	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—pancreatic cancer	0.000177	0.00278	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—pancreatic cancer	0.000176	0.00278	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000174	0.00275	CcSEcCtD
Nateglinide—Vomiting—Irinotecan—pancreatic cancer	0.000173	0.00273	CcSEcCtD
Nateglinide—Dizziness—Fluorouracil—pancreatic cancer	0.000173	0.00272	CcSEcCtD
Nateglinide—Rash—Irinotecan—pancreatic cancer	0.000172	0.00271	CcSEcCtD
Nateglinide—Dermatitis—Irinotecan—pancreatic cancer	0.000172	0.0027	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—pancreatic cancer	0.000169	0.00266	CcSEcCtD
Nateglinide—Vomiting—Gemcitabine—pancreatic cancer	0.000169	0.00266	CcSEcCtD
Nateglinide—Rash—Gemcitabine—pancreatic cancer	0.000167	0.00264	CcSEcCtD
Nateglinide—Dermatitis—Gemcitabine—pancreatic cancer	0.000167	0.00263	CcSEcCtD
Nateglinide—Vomiting—Fluorouracil—pancreatic cancer	0.000166	0.00261	CcSEcCtD
Nateglinide—Dyspepsia—Docetaxel—pancreatic cancer	0.000166	0.00261	CcSEcCtD
Nateglinide—Rash—Fluorouracil—pancreatic cancer	0.000165	0.00259	CcSEcCtD
Nateglinide—Dermatitis—Fluorouracil—pancreatic cancer	0.000164	0.00259	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000163	0.00257	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000163	0.00256	CcSEcCtD
Nateglinide—Fatigue—Docetaxel—pancreatic cancer	0.000162	0.00256	CcSEcCtD
Nateglinide—Nausea—Irinotecan—pancreatic cancer	0.000162	0.00255	CcSEcCtD
Nateglinide—Immune system disorder—Epirubicin—pancreatic cancer	0.000162	0.00254	CcSEcCtD
Nateglinide—Nausea—Gemcitabine—pancreatic cancer	0.000158	0.00248	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000157	0.00246	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—pancreatic cancer	0.000156	0.00245	CcSEcCtD
Nateglinide—Nausea—Fluorouracil—pancreatic cancer	0.000155	0.00244	CcSEcCtD
Nateglinide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000154	0.00243	CcSEcCtD
Nateglinide—Back pain—Epirubicin—pancreatic cancer	0.000151	0.00237	CcSEcCtD
Nateglinide—Immune system disorder—Doxorubicin—pancreatic cancer	0.00015	0.00235	CcSEcCtD
Nateglinide—Abdominal pain—Docetaxel—pancreatic cancer	0.000149	0.00235	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—pancreatic cancer	0.000144	0.00227	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—pancreatic cancer	0.000139	0.00219	CcSEcCtD
Nateglinide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000139	0.00219	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—pancreatic cancer	0.000138	0.00217	CcSEcCtD
Nateglinide—Cough—Epirubicin—pancreatic cancer	0.000136	0.00214	CcSEcCtD
Nateglinide—Asthenia—Docetaxel—pancreatic cancer	0.000135	0.00213	CcSEcCtD
Nateglinide—Pruritus—Docetaxel—pancreatic cancer	0.000133	0.0021	CcSEcCtD
Nateglinide—Diarrhoea—Docetaxel—pancreatic cancer	0.000129	0.00203	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—pancreatic cancer	0.000127	0.00201	CcSEcCtD
Nateglinide—Cough—Doxorubicin—pancreatic cancer	0.000126	0.00198	CcSEcCtD
Nateglinide—Dizziness—Docetaxel—pancreatic cancer	0.000125	0.00196	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000123	0.00193	CcSEcCtD
Nateglinide—Vomiting—Docetaxel—pancreatic cancer	0.00012	0.00189	CcSEcCtD
Nateglinide—Rash—Docetaxel—pancreatic cancer	0.000119	0.00187	CcSEcCtD
Nateglinide—Dermatitis—Docetaxel—pancreatic cancer	0.000119	0.00187	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000114	0.00179	CcSEcCtD
Nateglinide—Nausea—Docetaxel—pancreatic cancer	0.000112	0.00176	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—pancreatic cancer	0.000112	0.00176	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00011	0.00173	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—pancreatic cancer	0.00011	0.00173	CcSEcCtD
Nateglinide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000104	0.00164	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000104	0.00163	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000102	0.0016	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—pancreatic cancer	0.000101	0.0016	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—pancreatic cancer	0.000101	0.00159	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—pancreatic cancer	0.0001	0.00158	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.62e-05	0.00151	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—pancreatic cancer	9.36e-05	0.00147	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—pancreatic cancer	9.34e-05	0.00147	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—pancreatic cancer	9.3e-05	0.00146	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—pancreatic cancer	9.12e-05	0.00144	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—pancreatic cancer	8.99e-05	0.00142	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—pancreatic cancer	8.7e-05	0.00137	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—pancreatic cancer	8.66e-05	0.00136	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—pancreatic cancer	8.44e-05	0.00133	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—pancreatic cancer	8.4e-05	0.00132	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—pancreatic cancer	8.32e-05	0.00131	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—pancreatic cancer	8.08e-05	0.00127	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—pancreatic cancer	8.05e-05	0.00127	CcSEcCtD
Nateglinide—Rash—Epirubicin—pancreatic cancer	8.01e-05	0.00126	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—pancreatic cancer	8.01e-05	0.00126	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—pancreatic cancer	7.78e-05	0.00122	CcSEcCtD
Nateglinide—Nausea—Epirubicin—pancreatic cancer	7.55e-05	0.00119	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—pancreatic cancer	7.48e-05	0.00118	CcSEcCtD
Nateglinide—Rash—Doxorubicin—pancreatic cancer	7.42e-05	0.00117	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—pancreatic cancer	7.41e-05	0.00117	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—pancreatic cancer	6.99e-05	0.0011	CcSEcCtD
Nateglinide—PPARG—Metabolism—GCG—pancreatic cancer	1.25e-05	0.000431	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—DPYD—pancreatic cancer	1.24e-05	0.000429	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP9—pancreatic cancer	1.24e-05	0.000429	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—KRAS—pancreatic cancer	1.24e-05	0.000428	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	1.22e-05	0.000422	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	1.22e-05	0.00042	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC2A2—pancreatic cancer	1.18e-05	0.000407	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—STK11—pancreatic cancer	1.18e-05	0.000406	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TYMP—pancreatic cancer	1.17e-05	0.000403	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.17e-05	0.000403	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ARG2—pancreatic cancer	1.15e-05	0.000397	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—APOE—pancreatic cancer	1.15e-05	0.000396	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—SRC—pancreatic cancer	1.15e-05	0.000395	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—PIK3CA—pancreatic cancer	1.14e-05	0.000393	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.13e-05	0.000389	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CD44—pancreatic cancer	1.12e-05	0.000387	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SRC—pancreatic cancer	1.12e-05	0.000386	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—pancreatic cancer	1.12e-05	0.000385	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—APOE—pancreatic cancer	1.11e-05	0.000384	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—STAT3—pancreatic cancer	1.1e-05	0.000381	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.1e-05	0.000381	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—pancreatic cancer	1.1e-05	0.000381	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—NRAS—pancreatic cancer	1.1e-05	0.00038	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.1e-05	0.000379	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.1e-05	0.000378	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—APOE—pancreatic cancer	1.1e-05	0.000378	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MYC—pancreatic cancer	1.09e-05	0.000376	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—pancreatic cancer	1.09e-05	0.000376	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.09e-05	0.000375	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.09e-05	0.000375	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NRAS—pancreatic cancer	1.07e-05	0.000371	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GCG—pancreatic cancer	1.07e-05	0.000371	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HRAS—pancreatic cancer	1.05e-05	0.000364	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CG—pancreatic cancer	1.04e-05	0.000357	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.03e-05	0.000354	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TGFB1—pancreatic cancer	1.02e-05	0.000353	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TYMS—pancreatic cancer	1.01e-05	0.000349	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—STK11—pancreatic cancer	1.01e-05	0.000349	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TYMP—pancreatic cancer	1.01e-05	0.000347	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—pancreatic cancer	1e-05	0.000347	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CG—pancreatic cancer	1e-05	0.000347	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PPARG—pancreatic cancer	9.99e-06	0.000345	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TGFB1—pancreatic cancer	9.99e-06	0.000345	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CG—pancreatic cancer	9.89e-06	0.000342	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	9.81e-06	0.000339	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NOTCH1—pancreatic cancer	9.76e-06	0.000337	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PPARG—pancreatic cancer	9.69e-06	0.000334	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—pancreatic cancer	9.56e-06	0.00033	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	9.55e-06	0.00033	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PPARG—pancreatic cancer	9.55e-06	0.00033	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ARG2—pancreatic cancer	9.51e-06	0.000328	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—KRAS—pancreatic cancer	9.48e-06	0.000327	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.48e-06	0.000327	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ARG2—pancreatic cancer	9.43e-06	0.000325	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CD44—pancreatic cancer	9.42e-06	0.000325	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GLP1R—pancreatic cancer	9.42e-06	0.000325	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—AKT1—pancreatic cancer	9.31e-06	0.000321	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—DPYD—pancreatic cancer	9.27e-06	0.00032	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLAU—pancreatic cancer	9.25e-06	0.000319	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—KRAS—pancreatic cancer	9.25e-06	0.000319	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CD44—pancreatic cancer	9.13e-06	0.000315	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CD—pancreatic cancer	9.1e-06	0.000314	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GCG—pancreatic cancer	9.03e-06	0.000312	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.94e-06	0.000309	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.86e-06	0.000306	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CD—pancreatic cancer	8.83e-06	0.000305	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	8.79e-06	0.000304	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	8.77e-06	0.000303	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GCG—pancreatic cancer	8.76e-06	0.000302	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CD—pancreatic cancer	8.7e-06	0.0003	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TYMS—pancreatic cancer	8.69e-06	0.0003	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	8.5e-06	0.000293	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—STK11—pancreatic cancer	8.49e-06	0.000293	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMP—pancreatic cancer	8.31e-06	0.000287	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.31e-06	0.000287	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMP—pancreatic cancer	8.24e-06	0.000284	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CG—pancreatic cancer	8.23e-06	0.000284	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—STK11—pancreatic cancer	8.23e-06	0.000284	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—pancreatic cancer	8.22e-06	0.000284	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—APOE—pancreatic cancer	8.22e-06	0.000284	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—EGF—pancreatic cancer	8.14e-06	0.000281	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GLP1R—pancreatic cancer	8.11e-06	0.00028	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—pancreatic cancer	8.06e-06	0.000278	CbGpPWpGaD
Nateglinide—ALB—Metabolism—DPYD—pancreatic cancer	7.98e-06	0.000275	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CB—pancreatic cancer	7.93e-06	0.000274	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—pancreatic cancer	7.86e-06	0.000271	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—pancreatic cancer	7.86e-06	0.000271	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.78e-06	0.000269	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.73e-06	0.000267	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CB—pancreatic cancer	7.69e-06	0.000266	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—pancreatic cancer	7.62e-06	0.000263	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CB—pancreatic cancer	7.58e-06	0.000262	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC2A2—pancreatic cancer	7.57e-06	0.000261	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—pancreatic cancer	7.51e-06	0.000259	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.5e-06	0.000259	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	7.46e-06	0.000258	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CG—pancreatic cancer	7.42e-06	0.000256	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TYMS—pancreatic cancer	7.31e-06	0.000252	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CD—pancreatic cancer	7.24e-06	0.00025	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.23e-06	0.00025	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.17e-06	0.000247	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—pancreatic cancer	7.12e-06	0.000246	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TYMS—pancreatic cancer	7.08e-06	0.000244	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOE—pancreatic cancer	7.06e-06	0.000244	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—pancreatic cancer	6.94e-06	0.00024	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTEN—pancreatic cancer	6.86e-06	0.000237	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CD44—pancreatic cancer	6.81e-06	0.000235	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.8e-06	0.000235	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GLP1R—pancreatic cancer	6.7e-06	0.000231	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.69e-06	0.000231	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTEN—pancreatic cancer	6.65e-06	0.000229	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GLP1R—pancreatic cancer	6.64e-06	0.000229	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—DPYD—pancreatic cancer	6.59e-06	0.000227	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.59e-06	0.000227	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTEN—pancreatic cancer	6.55e-06	0.000226	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—DPYD—pancreatic cancer	6.53e-06	0.000226	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GCG—pancreatic cancer	6.53e-06	0.000225	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CD—pancreatic cancer	6.52e-06	0.000225	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	6.38e-06	0.00022	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CB—pancreatic cancer	6.31e-06	0.000218	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	6.25e-06	0.000216	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.22e-06	0.000215	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	6.2e-06	0.000214	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—pancreatic cancer	6.15e-06	0.000212	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—STK11—pancreatic cancer	6.14e-06	0.000212	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.14e-06	0.000212	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	6.1e-06	0.00021	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOE—pancreatic cancer	5.94e-06	0.000205	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.92e-06	0.000204	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CD44—pancreatic cancer	5.87e-06	0.000202	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOE—pancreatic cancer	5.76e-06	0.000199	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.74e-06	0.000198	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.69e-06	0.000196	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CB—pancreatic cancer	5.69e-06	0.000196	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—pancreatic cancer	5.63e-06	0.000194	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GCG—pancreatic cancer	5.62e-06	0.000194	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	5.6e-06	0.000193	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.45e-06	0.000188	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.43e-06	0.000188	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.39e-06	0.000186	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	5.36e-06	0.000185	CbGpPWpGaD
Nateglinide—ALB—Metabolism—STK11—pancreatic cancer	5.29e-06	0.000182	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TYMS—pancreatic cancer	5.28e-06	0.000182	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—pancreatic cancer	5.25e-06	0.000181	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—pancreatic cancer	5.2e-06	0.000179	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—pancreatic cancer	5.18e-06	0.000179	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SRC—pancreatic cancer	5.06e-06	0.000175	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—pancreatic cancer	5.02e-06	0.000173	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.96e-06	0.000171	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—pancreatic cancer	4.92e-06	0.00017	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTEN—pancreatic cancer	4.91e-06	0.00017	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	4.89e-06	0.000169	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NRAS—pancreatic cancer	4.86e-06	0.000168	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CD44—pancreatic cancer	4.84e-06	0.000167	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—pancreatic cancer	4.84e-06	0.000167	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—pancreatic cancer	4.84e-06	0.000167	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CD44—pancreatic cancer	4.8e-06	0.000166	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	4.71e-06	0.000163	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.7e-06	0.000162	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—pancreatic cancer	4.69e-06	0.000162	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.66e-06	0.000161	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GCG—pancreatic cancer	4.64e-06	0.00016	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—pancreatic cancer	4.62e-06	0.00016	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GCG—pancreatic cancer	4.6e-06	0.000159	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CD—pancreatic cancer	4.57e-06	0.000158	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TYMS—pancreatic cancer	4.55e-06	0.000157	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—pancreatic cancer	4.52e-06	0.000156	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.38e-06	0.000151	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STK11—pancreatic cancer	4.37e-06	0.000151	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STK11—pancreatic cancer	4.33e-06	0.000149	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.31e-06	0.000149	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—pancreatic cancer	4.29e-06	0.000148	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTEN—pancreatic cancer	4.22e-06	0.000146	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—pancreatic cancer	4.19e-06	0.000144	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	4.11e-06	0.000142	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.09e-06	0.000141	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—pancreatic cancer	4.07e-06	0.000141	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.06e-06	0.00014	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CB—pancreatic cancer	3.98e-06	0.000137	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—pancreatic cancer	3.95e-06	0.000136	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—pancreatic cancer	3.95e-06	0.000136	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	3.88e-06	0.000134	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—pancreatic cancer	3.85e-06	0.000133	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—pancreatic cancer	3.83e-06	0.000132	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—pancreatic cancer	3.78e-06	0.00013	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.76e-06	0.00013	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—pancreatic cancer	3.74e-06	0.000129	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.72e-06	0.000128	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—pancreatic cancer	3.72e-06	0.000128	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—pancreatic cancer	3.7e-06	0.000128	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—pancreatic cancer	3.64e-06	0.000126	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—pancreatic cancer	3.56e-06	0.000123	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTEN—pancreatic cancer	3.55e-06	0.000123	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.5e-06	0.000121	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—pancreatic cancer	3.47e-06	0.00012	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTEN—pancreatic cancer	3.44e-06	0.000119	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	3.41e-06	0.000118	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—pancreatic cancer	3.34e-06	0.000115	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—pancreatic cancer	3.22e-06	0.000111	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CD44—pancreatic cancer	3.17e-06	0.000109	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—pancreatic cancer	3.14e-06	0.000108	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—pancreatic cancer	3.05e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCG—pancreatic cancer	3.04e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—pancreatic cancer	3.03e-06	0.000105	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	2.98e-06	0.000103	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	2.97e-06	0.000103	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—pancreatic cancer	2.94e-06	0.000102	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CD—pancreatic cancer	2.93e-06	0.000101	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.87e-06	9.89e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STK11—pancreatic cancer	2.85e-06	9.85e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—pancreatic cancer	2.83e-06	9.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.76e-06	9.51e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.73e-06	9.43e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.66e-06	9.18e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.64e-06	9.1e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.57e-06	8.86e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CB—pancreatic cancer	2.56e-06	8.83e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—pancreatic cancer	2.53e-06	8.75e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.5e-06	8.65e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.46e-06	8.47e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—pancreatic cancer	2.43e-06	8.4e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—pancreatic cancer	2.43e-06	8.38e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.42e-06	8.36e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.4e-06	8.29e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTEN—pancreatic cancer	2.21e-06	7.63e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.11e-06	7.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	7.23e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.09e-06	7.22e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.07e-06	7.16e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.05e-06	7.06e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—pancreatic cancer	2e-06	6.89e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—pancreatic cancer	1.98e-06	6.85e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.82e-06	6.3e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.81e-06	6.25e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.81e-06	6.24e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.8e-06	6.22e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.74e-06	6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.58e-06	5.47e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—pancreatic cancer	1.56e-06	5.38e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.48e-06	5.11e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.38e-06	4.77e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.37e-06	4.72e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.29e-06	4.44e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.28e-06	4.41e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—pancreatic cancer	1.27e-06	4.4e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.19e-06	4.12e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.05e-06	3.63e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.04e-06	3.6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	8.42e-07	2.91e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.88e-07	2.37e-05	CbGpPWpGaD
